DrugDashboards

Sevelamer Carbonate

Sevelamer Carbonate · SEVELAMER CARBONATE 2.4 g/1 · Powder, For Suspension · Oral · Sanofi-Aventis U.S. LLC

NDC 00955-1054-90 · 90 PACKET in 1 BOX / 1 POWDER, FOR SUSPENSION in 1 PACKET · NDA AUTHORIZED GENERIC · View full market →

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The price has fallen 43% in a year, to $2.01 per unit — and generics that get this cheap tend to get abandoned rather than defended.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$5.00$10.00$15.00Nov 2018Jul 2024$2.01
9 price points · per · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$851.00
Reported to Texas DSHS · 2024 annual filing · Sanofi-Aventis US LLC

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2023)

$122,284
194 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for sevelamer carbonate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA022318
TE code
—
Approval date
Feb 18, 2009
Patents / exclusivity
2 patents, 0 exclusivities
TypeNumber / codeExpires
patent9095509Dec 6, 2030
patent9095509Dec 6, 2030

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Sevelamer Carbonate (Powder, For Suspension)

LabelerStrengthFirst seenLast seen
Amneal Pharmaceuticals of New York LLCSEVELAMER CARBONATE 800 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals of New York LLCSEVELAMER CARBONATE 2400 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedSEVELAMER CARBONATE 2400 mg/1Jul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedSEVELAMER CARBONATE 800 mg/1Jul 15, 2026Sep 2, 2026
Bionpharma Inc.SEVELAMER CARBONATE 800 mg/1Jul 15, 2026Sep 2, 2026
Bionpharma Inc.SEVELAMER CARBONATE 2400 mg/1Jul 15, 2026Sep 2, 2026
Genzyme CorporationSEVELAMER CARBONATE 800 mg/1Jul 15, 2026Sep 2, 2026
Genzyme CorporationSEVELAMER CARBONATE 2400 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedSEVELAMER CARBONATE .8 g/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedSEVELAMER CARBONATE 2.4 g/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCSEVELAMER CARBONATE .8 g/1Jul 15, 2026Sep 2, 2026
Sanofi-Aventis U.S. LLCSEVELAMER CARBONATE .8 g/1Jul 15, 2026Sep 2, 2026
Sanofi-Aventis U.S. LLCSEVELAMER CARBONATE 2.4 g/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sevelamer Carbonate — NDC 00955-1054-90," retrieved September 3, 2026, https://drugdashboards.com/drug/00955105490.

Free to cite with attribution — see how the data is put together.